News and Publications2022-09-10T02:30:43-07:00

News and Events

Recent News and Publications



October 20, 2020

Novel Dual MTOR Inhibitor/AMPK Activator Mitigates Doxorubicin Cardiotoxicity And Potentiates Its Chemotherapeutic Efficacy Against Triple Negative Breast Cancer”, Scientific Sessions 2020

April 26, 2020

Synergistic anti-metastatic effect of pembrolizumab in combination with a novel mTORC1 inhibitor/AMPK agonist in a CAM metastatic triple negative breast cancer model,  Virtual AACR 2020 Annual Meeting

August 2019

“Novel Dual MTOR Inhibitors/AMPK Activators Attenuate Doxorubicin-induced Cardiotoxicity” Rapid Fire Oral Presentation in American Heart Association Scientific Sessions

August 2018

A novel fibroblast activation inhibitor attenuates left ventricular remodeling and preserves cardiac function in heart failure, American Journal of Physiology Heart and Circulatory Physiology


AHA 2022 Meeting

The premier global event focusing on improving health by championing scientific discovery and practice-changing educational content.

November 5, 2022|

Life Sciences Summit (LSS)

The conference features corporate presentations by promising young companies with transformative science that targets unmet medical needs.

November 9, 2021|

AACR 2020

Highlights the work of the best minds in research and medicine from institutions all over the world.

June 22, 2020|
Go to Top